MARKET

RENXF

RENXF

Renalytix Plc
OTCMQB
0.163
NaN%
Closed 09:30 12/05 EST
OPEN
--
PREV CLOSE
0.163
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.621
52 WEEK LOW
0.163
MARKET CAP
71.23M
P/E (TTM)
-2.1938
1D
5D
1M
3M
1Y
5Y
1D
Renalytix AI Reports Strong Growth and Strategic Expansion
TipRanks · 2d ago
Renalytix Publishes Pivotal KidneyIntelX.dkd Data Demonstrating Improved CKD Risk Prediction
Reuters · 11/18 12:51
Renalytix’s KidneyIntelX.dkd Test Gains Recognition for Advancing CKD Management
TipRanks · 11/12 07:33
Renalytix Publishes 2025 Annual Report and Expands Kidney Disease Test Deployment
TipRanks · 11/04 18:07
Renalytix Reports Strong Fiscal 2025 Results and Strategic Expansion
TipRanks · 11/03 07:14
Renalytix Secures £860k in R&D Tax Credits
TipRanks · 10/27 07:12
Renalytix Enhances Financial Position with $4M Bond Conversion
TipRanks · 10/10 06:11
Renalytix Secures £7.05 Million in Oversubscribed Fundraise
TipRanks · 09/26 06:12
More
About RENXF
Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. KidneyIntelX, is a vitro diagnostic platform, employs a proprietary algorithm that combines diverse data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record or EHR, systems, to generate a patient risk score. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.

Webull offers Renalytix PLC stock information, including OTCMQB: RENXF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RENXF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RENXF stock methods without spending real money on the virtual paper trading platform.